|
Hikma Halts Production at NJ Plant Following Warning Letter
Hikma Pharmaceuticals will cease commercial production at its Eatontown, N.J., plant through mid-January to focus on bringing the facility back into compliance with good manufacturing practice regulations following a February 2012 warning letter.
This article is viewable by subscribers only. To view this article, please select an option below.
|
Subscribe
Archives